Clinical Trial Update: Vitamin K and Bone Turnover in Postmenopausal Women [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Vitamin K (phylloquinone) on bone turnover in postmenopausal women with osteoporosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Vitamin K (Vitamin K)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED